Industry wins reprieve as European ministers postpone ban on animal-derived risk materials
This article was originally published in Clinica
The European Council of Ministers has voted to postpone the European Commission's ban on materials containing specified risk materials for another year. This means that the medical devices industry will not have to respond after January 1, as had been expected. The Council took its decision just two weeks before the ban (Decision 97/534) was due to take effect.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.